A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Clinical trial NCT07491458 · RECRUITING
Trial details
- NCT number
- NCT07491458
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-13
- Primary completion
- 2027-02-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.